Medical experts have warned Britons not to turn to fake weight loss jabs after fears the Mounjaro price hike could make it unaffordable for people “already struggling to pay for it”.
The cost of the drug, dubbed the “King Kong” of weight loss medicine, is set to triple in the UK after its US-owned company equalised costs in markets across the globe.